Private Capital Advisors Inc. cut its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 7.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 34,132 shares of the healthcare conglomerate’s stock after selling 2,593 shares during the quarter. UnitedHealth Group makes up 2.6% of Private Capital Advisors Inc.’s investment portfolio, making the stock its 8th largest position. Private Capital Advisors Inc.’s holdings in UnitedHealth Group were worth $7,525,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently modified their holdings of UNH. Capital International Investors grew its holdings in shares of UnitedHealth Group by 399.3% during the third quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock worth $809,370,000 after buying an additional 3,304,902 shares in the last quarter. Jennison Associates LLC grew its holdings in UnitedHealth Group by 146.0% in the third quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock valued at $1,085,396,000 after purchasing an additional 3,289,470 shares during the period. Janus Henderson Group PLC grew its holdings in UnitedHealth Group by 1,820.1% in the second quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after purchasing an additional 2,264,242 shares during the period. Vanguard Group Inc. grew its holdings in UnitedHealth Group by 2.5% in the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after purchasing an additional 1,588,516 shares during the period. Finally, Parametric Portfolio Associates LLC grew its holdings in UnitedHealth Group by 77.3% in the second quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock valued at $664,570,000 after purchasing an additional 1,562,661 shares during the period. Institutional investors and hedge funds own 86.00% of the company’s stock.
In other news, Director Kenneth Irwin Shine sold 198 shares of the business’s stock in a transaction on Friday, January 19th. The shares were sold at an average price of $242.55, for a total transaction of $48,024.90. Following the transaction, the director now directly owns 1,790,567 shares of the company’s stock, valued at $434,302,025.85. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director William C. Ballard, Jr. sold 10,000 shares of the business’s stock in a transaction on Tuesday, January 23rd. The stock was sold at an average price of $246.38, for a total transaction of $2,463,800.00. Following the transaction, the director now directly owns 76,637 shares in the company, valued at $18,881,824.06. The disclosure for this sale can be found here. Over the last three months, insiders have sold 53,396 shares of company stock worth $12,262,067. Corporate insiders own 0.89% of the company’s stock.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, beating analysts’ consensus estimates of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The firm had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.57 billion. During the same period in the previous year, the company posted $2.11 earnings per share. UnitedHealth Group’s revenue was up 9.5% compared to the same quarter last year. equities research analysts predict that UnitedHealth Group Inc will post 12.51 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th will be given a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, March 8th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.31%. UnitedHealth Group’s payout ratio is currently 31.58%.
UNH has been the subject of a number of recent analyst reports. Cantor Fitzgerald restated a “buy” rating and issued a $225.00 target price on shares of UnitedHealth Group in a report on Monday, November 27th. Jefferies Group restated a “buy” rating and issued a $248.00 target price on shares of UnitedHealth Group in a report on Friday, December 1st. Deutsche Bank boosted their target price on shares of UnitedHealth Group to $260.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Credit Suisse Group initiated coverage on shares of UnitedHealth Group in a report on Thursday, November 2nd. They issued an “outperform” rating and a $233.00 target price for the company. Finally, Royal Bank of Canada boosted their target price on shares of UnitedHealth Group to $244.00 and gave the company an “outperform” rating in a report on Wednesday, November 29th. They noted that the move was a valuation call. Two analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $243.22.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.